Obmutesce pater mendacii ✠ Be silent, father of lies
The full first line protocol for vaccine injury is as follows. Keep in mind, however, that the treatment must be individualized to the symptoms of each patient. As explained by Marik, the patient's response will determine future treatment and adjunct therapies. These are not symptom specific but rather listed in order of importance:10
Time Restricted Eating or periodic daily fasts. Fasting has a profound effect on promoting immune system homeostasis, partly by stimulating the removal of damaged cells and mitochondria and clearing misfolded and foreign proteins. Intermittent fasting likely has an important role in promoting the breakdown and elimination of the spike protein. Fasting is contraindicated in patients under 18 (impairs growth) and during pregnancy and breastfeeding.
Patients with diabetes, as well as those with serious underlying medical conditions, should consult their primary care provider prior to fasting, as changes in their medications may be required and these patients require close monitoring.
Ivermectin — 0.2 to 0.3 mg/kg, daily for up to 4 to 6 weeks. Ivermectin has potent anti-inflammatory properties. It also binds to the spike protein, aiding in the elimination by the host. It is likely that ivermectin and intermittent fasting act synergistically to rid the body of the spike protein.
Ivermectin is best taken with or just following a meal for greater absorption. A trial of ivermectin should be considered as first line therapy. It appears that patients can be grouped into two categories: i) ivermectin responders and ii) ivermectin nonresponders.
This distinction is important, as the latter are more difficult to treat and require more aggressive therapy. Due to the possible drug interaction between quercetin and ivermectin, these drugs should not be taken simultaneously (i.e., should be staggered morning and night).
Low dose naltrexone (LDN) — Begin with 1 mg/day and increase to 4.5 mg/day, as required. May take 2 to 3 months to see full effect. LDN has been demonstrated to have anti-inflammatory, analgesic and neuromodulating properties.
Melatonin — 2 to 6 mg slow release/extended release prior to bedtime. Melatonin has anti-inflammatory and antioxidant properties and is a powerful regulator of mitochondrial function. The dose should be started at 750 mcg (ΞΌg) to 1 mg at night and increased as tolerated. Patients who are slow metabolizers may have very unpleasant and vivid dreams with higher doses.
Aspirin — 81 mg/day. (Please note: I do not agree with the routine use of aspirin, and recommend proteolytic enzymes such as lumbrokinase and serrapeptase on an empty stomach instead. Both serve to digest unwanted proteins in your blood, like blood clots.
They also help combat inflammation and rebalance your immune system, facilitating the removal of inflammatory proteins, removing fibrin — a clotting material that restricts blood flow and prolongs inflammation — reducing edema in inflamed regions, and boosting the potency of macrophages and killer cells.)
Vitamin C — 1000 mg orally three to four times a day. Vitamin C has important anti-inflammatory, antioxidant, and immune-enhancing properties, including increased synthesis of type I interferons. Avoid in patients with a history of kidney stones. Oral Vitamin C helps promote growth of protective bacterial populations in the microbiome.
It is important to note that these high doses are a pharmaceutical application of vitamin C and NOT recommended for daily use. It is far better to use whole food vitamin C and not ascorbic acid for daily use. I actually will be speaking with Dr. Marik and Korey September 9 and 10 at a vitamin C conference11 in Clearwater, Florida. If you come to the event you will be able to meet me personally there.
Vitamin D and Vitamin K2 — A dose of 4,000 to 5,000 units/day of vitamin D, together with vitamin K2 100 mcg/day is a reasonable starting dose. The dose of Vitamin D should be adjusted according to the baseline vitamin D level.
Quercetin — 250 to 500 mg/day (or mixed flavonoids). Flavonoids have broad spectrum anti-inflammatory properties, inhibit mast cells, and have been demonstrated to reduce neuroinflammation.
Due to a possible drug interaction between quercetin and ivermectin, these drugs should not be taken simultaneously (i.e., should be staggered morning and night). The use of quercetin has rarely been associated with hypothyroidism.
The clinical impact of this association may be limited to those individuals with preexistent thyroid disease or those with subclinical thyroidism. Quercetin should be used with caution in patients with hypothyroidism and TSH levels should be monitored.
